ID   QG-U
AC   CVCL_3778
SY   QGU
DR   CLO; CLO_0050919
DR   BioSample; SAMN03472215
DR   Cosmic; 877463
DR   Cosmic; 925360
DR   Cosmic; 1152543
DR   RCB; RCB0688
DR   Wikidata; Q54948821
RX   PubMed=571828;
RX   PubMed=3029293;
RX   PubMed=6991350;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=6991350).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
ST   Source(s): RCB
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,19
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   PubMed=571828; DOI=10.20772/cancersci1959.70.1_1;
RA   Matsunaga K., Mashiba H., Gojobori M., Jimi S.;
RT   "Antibody-dependent cell-mediated cytotoxicity of sera from cancer
RT   patients against cultured cervical cancer cell lines.";
RL   Gann 70:1-7(1979).
//
RX   PubMed=3029293; DOI=10.1099/0022-1317-68-2-583;
RA   Shirasawa H., Tomita Y., Sekiya S., Takamizawa H., Simizu B.;
RT   "Integration and transcription of human papillomavirus type 16 and 18
RT   sequences in cell lines derived from cervical carcinomas.";
RL   J. Gen. Virol. 68:583-591(1987).
//
RX   PubMed=6991350; DOI=10.20772/cancersci1959.71.1_73;
RA   Matsunaga K., Mashiba H., Gojobori M.;
RT   "Cytostatic activity of in vitro activated human adherent cells
RT   against human tumor cell lines.";
RL   Gann 71:73-79(1980).
//